Ballentine Partners, LLC Alcon Inc Transaction History
Ballentine Partners, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Ballentine Partners, LLC transactions in Alcon Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 3,524 shares of ALC stock, worth $273,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,524
Previous 4,250
17.08%
Holding current value
$273,638
Previous $375,000
30.13%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ALC
# of Institutions
776Shares Held
244MCall Options Held
14.2MPut Options Held
7.33M-
Vanguard Group Inc Valley Forge, PA21.5MShares$1.67 Billion0.03% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.2 Billion1.27% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA10.7MShares$831 Million1.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.3MShares$796 Million0.08% of portfolio
-
Ako Capital Ako Capital LLP | London, X07.97MShares$619 Million8.44% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $38.1B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...